Drugs / 18F-FluorApoTrace
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05048732 | Dec 2021 → Feb 2024 | diffuse large B-cell lymphoma | Washington University School of Medicine | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 18F-FluorApoTrace | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05048732 ↗ |
| Modality | Diagnostic / imaging agent | “18F-FAT PET/CT imaging” NCT05048732 ↗ |